Screening for partial deletions in the CREBBP gene in Rubinstein-Taybi syndrome patients using multiplex PCR/liquid chromatography

Toru Udaka, Kenji Kurosawa, Kosuke Izumi, Shinobu Yoshida, Masato Tsukahara, Nobuhiko Okamoto, Chiharu Torii, Rika Kosaki, Mitsuo Masuno, Noboru Hosokai, Takao Takahashi, Kenjiro Kosaki

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Rubinstein-Taybi syndrome (RTS, MIM 180849) is a multiple malformation syndrome characterized by growth retardation, developmental delay, and dysmorphic features, including down-slanting palpebral fissures, a beaked nose, broad thumbs, and halluces. Mutations in the gene encoding the CREB-binding protein gene (CREBBP, also known as CBP) on chromosome 16p13.3 were identified in 1995. Recently, we developed a mutation analysis protocol using denaturing high-performance liquid chromatography (DHPLC) and identified heterozygous CREBBP mutations in 12 of 21 RTS patients. To test whether exonic deletions represent a common pathogenic mechanism, we assessed the copy number of all the coding exons using a recently developed method, the multiplex PCR/liquid chromatography assay (MP/LC). By using MP/LC, we performed screening for CREBBP exonic deletions among 25 RTS patients in whom no point mutations or small insertions/deletions were identified by DHPLC screening. We identified four classic RTS patients with deletions encompassing multiple exons (14-16, 5-31, 1-16, and 4-26). We conclude that large deletions including several exons are a relatively frequent cause of RTS, and that MP/LC is an effective method for detecting these deletions.

Original languageEnglish
Pages (from-to)265-271
Number of pages7
JournalGenetic Testing
Volume10
Issue number4
DOIs
Publication statusPublished - 2006 Dec

Fingerprint

Rubinstein-Taybi Syndrome
Multiplex Polymerase Chain Reaction
Liquid Chromatography
Exons
Mutation
High Pressure Liquid Chromatography
CREB-Binding Protein
Hallux
Genes
Thumb
Eyelids
Nose
Point Mutation
Chromosomes
Growth

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Screening for partial deletions in the CREBBP gene in Rubinstein-Taybi syndrome patients using multiplex PCR/liquid chromatography. / Udaka, Toru; Kurosawa, Kenji; Izumi, Kosuke; Yoshida, Shinobu; Tsukahara, Masato; Okamoto, Nobuhiko; Torii, Chiharu; Kosaki, Rika; Masuno, Mitsuo; Hosokai, Noboru; Takahashi, Takao; Kosaki, Kenjiro.

In: Genetic Testing, Vol. 10, No. 4, 12.2006, p. 265-271.

Research output: Contribution to journalArticle

Udaka, T, Kurosawa, K, Izumi, K, Yoshida, S, Tsukahara, M, Okamoto, N, Torii, C, Kosaki, R, Masuno, M, Hosokai, N, Takahashi, T & Kosaki, K 2006, 'Screening for partial deletions in the CREBBP gene in Rubinstein-Taybi syndrome patients using multiplex PCR/liquid chromatography', Genetic Testing, vol. 10, no. 4, pp. 265-271. https://doi.org/10.1089/gte.2006.10.265
Udaka, Toru ; Kurosawa, Kenji ; Izumi, Kosuke ; Yoshida, Shinobu ; Tsukahara, Masato ; Okamoto, Nobuhiko ; Torii, Chiharu ; Kosaki, Rika ; Masuno, Mitsuo ; Hosokai, Noboru ; Takahashi, Takao ; Kosaki, Kenjiro. / Screening for partial deletions in the CREBBP gene in Rubinstein-Taybi syndrome patients using multiplex PCR/liquid chromatography. In: Genetic Testing. 2006 ; Vol. 10, No. 4. pp. 265-271.
@article{87e24e4210f0465a800a952c9d68f20d,
title = "Screening for partial deletions in the CREBBP gene in Rubinstein-Taybi syndrome patients using multiplex PCR/liquid chromatography",
abstract = "Rubinstein-Taybi syndrome (RTS, MIM 180849) is a multiple malformation syndrome characterized by growth retardation, developmental delay, and dysmorphic features, including down-slanting palpebral fissures, a beaked nose, broad thumbs, and halluces. Mutations in the gene encoding the CREB-binding protein gene (CREBBP, also known as CBP) on chromosome 16p13.3 were identified in 1995. Recently, we developed a mutation analysis protocol using denaturing high-performance liquid chromatography (DHPLC) and identified heterozygous CREBBP mutations in 12 of 21 RTS patients. To test whether exonic deletions represent a common pathogenic mechanism, we assessed the copy number of all the coding exons using a recently developed method, the multiplex PCR/liquid chromatography assay (MP/LC). By using MP/LC, we performed screening for CREBBP exonic deletions among 25 RTS patients in whom no point mutations or small insertions/deletions were identified by DHPLC screening. We identified four classic RTS patients with deletions encompassing multiple exons (14-16, 5-31, 1-16, and 4-26). We conclude that large deletions including several exons are a relatively frequent cause of RTS, and that MP/LC is an effective method for detecting these deletions.",
author = "Toru Udaka and Kenji Kurosawa and Kosuke Izumi and Shinobu Yoshida and Masato Tsukahara and Nobuhiko Okamoto and Chiharu Torii and Rika Kosaki and Mitsuo Masuno and Noboru Hosokai and Takao Takahashi and Kenjiro Kosaki",
year = "2006",
month = "12",
doi = "10.1089/gte.2006.10.265",
language = "English",
volume = "10",
pages = "265--271",
journal = "Genetic Testing and Molecular Biomarkers",
issn = "1945-0265",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Screening for partial deletions in the CREBBP gene in Rubinstein-Taybi syndrome patients using multiplex PCR/liquid chromatography

AU - Udaka, Toru

AU - Kurosawa, Kenji

AU - Izumi, Kosuke

AU - Yoshida, Shinobu

AU - Tsukahara, Masato

AU - Okamoto, Nobuhiko

AU - Torii, Chiharu

AU - Kosaki, Rika

AU - Masuno, Mitsuo

AU - Hosokai, Noboru

AU - Takahashi, Takao

AU - Kosaki, Kenjiro

PY - 2006/12

Y1 - 2006/12

N2 - Rubinstein-Taybi syndrome (RTS, MIM 180849) is a multiple malformation syndrome characterized by growth retardation, developmental delay, and dysmorphic features, including down-slanting palpebral fissures, a beaked nose, broad thumbs, and halluces. Mutations in the gene encoding the CREB-binding protein gene (CREBBP, also known as CBP) on chromosome 16p13.3 were identified in 1995. Recently, we developed a mutation analysis protocol using denaturing high-performance liquid chromatography (DHPLC) and identified heterozygous CREBBP mutations in 12 of 21 RTS patients. To test whether exonic deletions represent a common pathogenic mechanism, we assessed the copy number of all the coding exons using a recently developed method, the multiplex PCR/liquid chromatography assay (MP/LC). By using MP/LC, we performed screening for CREBBP exonic deletions among 25 RTS patients in whom no point mutations or small insertions/deletions were identified by DHPLC screening. We identified four classic RTS patients with deletions encompassing multiple exons (14-16, 5-31, 1-16, and 4-26). We conclude that large deletions including several exons are a relatively frequent cause of RTS, and that MP/LC is an effective method for detecting these deletions.

AB - Rubinstein-Taybi syndrome (RTS, MIM 180849) is a multiple malformation syndrome characterized by growth retardation, developmental delay, and dysmorphic features, including down-slanting palpebral fissures, a beaked nose, broad thumbs, and halluces. Mutations in the gene encoding the CREB-binding protein gene (CREBBP, also known as CBP) on chromosome 16p13.3 were identified in 1995. Recently, we developed a mutation analysis protocol using denaturing high-performance liquid chromatography (DHPLC) and identified heterozygous CREBBP mutations in 12 of 21 RTS patients. To test whether exonic deletions represent a common pathogenic mechanism, we assessed the copy number of all the coding exons using a recently developed method, the multiplex PCR/liquid chromatography assay (MP/LC). By using MP/LC, we performed screening for CREBBP exonic deletions among 25 RTS patients in whom no point mutations or small insertions/deletions were identified by DHPLC screening. We identified four classic RTS patients with deletions encompassing multiple exons (14-16, 5-31, 1-16, and 4-26). We conclude that large deletions including several exons are a relatively frequent cause of RTS, and that MP/LC is an effective method for detecting these deletions.

UR - http://www.scopus.com/inward/record.url?scp=33846706462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846706462&partnerID=8YFLogxK

U2 - 10.1089/gte.2006.10.265

DO - 10.1089/gte.2006.10.265

M3 - Article

VL - 10

SP - 265

EP - 271

JO - Genetic Testing and Molecular Biomarkers

JF - Genetic Testing and Molecular Biomarkers

SN - 1945-0265

IS - 4

ER -